tirzepatide side effects first week Effects: Risks, Safety, and Support at Thrive Medicine Clinic in Houston Heights week 1 tirzepatide results My
Description
The MHRA approved the Wegovy pill (oral semaglutide 25 mg) in June 2026, and it reached private providers in July 2026

Rosenstock J, Wysham C, Frias JP, et al

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

Look for products with well-researched strains like Lactobacillus rhamnosus GG or Saccharomyces boulardii

While they typically improve over time, their impact on hydration status can be significant

Last reviewed: June 11, 2026 Last updated: June 11, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations